COV : Analysis & Opinions

  1. Masimo's Multigas Monitoring Module Gets 510(k), CE Mark - Analyst ...

    December 17, 2014
    Masimo Corporation's (MASI) ISA OR+ multigas monitoring is a Masimo Open Connect (MOC-9) Module for the Root patient monitoring ...
  2. Will MedTech Gain from Republican Promises? - Industry Outlook

    December 4, 2014
    Will MedTech Gain from Republican Promises? - Industry Outlook
  3. Capitalize On Wall Street's Latest Tax Craze

    September 18, 2014
    A couple weeks ago in StreetAuthority Daily, we talked about some of Corporate America's latest financial engineering ...
  4. Wall Street's Latest Tax Craze... And How To Profit

    September 18, 2014
    A couple weeks ago in StreetAuthority Daily, we talked about some of Corporate America's latest financial engineering ...
  5. MedTech Defies Sequestration, M&As Steal the Show - Industry ...

    August 26, 2014
    MedTech Defies Sequestration, M&As Steal the Show - Industry Outlook
  6. With so many Americans entering their golden years there will be plenty of profit in medical device stocks. Here are a few names to watch.

    Your Best Bet In The Medical Space

    July 1, 2014
    With so many Americans entering their golden years there will be plenty of profit in medical device stocks. Here are a few ...
  7. MedTech's Partial Tax Repeal: Is It Enough? - Industry Outlook

    May 1, 2014
    MedTech's Partial Tax Repeal: Is It Enough? - Industry Outlook
  8. MedTech Industry Stock Update - Sept 2013 - Industry Outlook

    September 10, 2013
    MedTech Industry Stock Update - Sept 2013 - Industry Outlook
  9. The Street Has Caught Covidien

    August 1, 2013
    Covidien's quality isn't the issue, but Wall Street's love for it may be.
  10. Stryker Seems Back On Track

    July 19, 2013
    Stryker's revenue growth looks fine, but there are still pressures in the end markets.
  11. Abbott Adds Two Promising Products

    July 15, 2013
    Abbott makes two solid growth acquisitions that should address large markets.
  12. Intuitive Surgical's Miss Looks Systemic And Company-Specific

    July 9, 2013
    A surprising drop in U.S. system placements is going to put Intuitive Surgical in the penalty box.
  13. It Gets A Little Harder From Here For Covidien

    April 29, 2013
    Expectations are the bigger issue for Covidien, as underlying growth is still pretty good on a relative basis.
  14. Is Controversy About Robot-Assisted Surgery Showing In Intuitive ...

    April 19, 2013
    Uncertainty about procedure growth may be opening a window in these often-expensive shares
  15. Pharma Is Doing All The Pulling For Johnson & Johnson

    April 17, 2013
    Although JNJ reported decent earnings and has some major new drugs lined up - downside risk is definitely still present.
  16. AngioDynamics Still Struggling To Get Back On Track

    April 10, 2013
    Ongoing revenue growth struggles and eroding market share is making the deep-value case harder at AngioDynamics.
  17. Hanger Beats Squarely; Profit Soars - Analyst Blog

    February 14, 2013
    Hanger Inc.'s (HGR) adjusted earnings of 58 cents per share for the fourth quarter of 2012 were 2 cents above the Zacks Consensus ...
  18. Covidien Issues STAR Trial Data - Analyst Blog

    February 8, 2013
    International health care products major, Covidien plc. (COV) announced results of the two-year "Solitaire FR Thrombectomy ...
  19. Shabby Reporting And Questionable Prospects At Abbott Labs

    January 28, 2013
    Poor reporting and weak margins undermine the potential of Abbott.
  20. Smith & Nephew's Costly Deal

    November 29, 2012
    Smith & Nephew is having to pay a pretty hefty price for this growth injection and this just isn't a sustainable long-term ...
  21. Endo Health Solutions Needs Some Solutions Of Its Own

    November 7, 2012
    Can Endo reestablish itself as a quality healthcare name?
  22. Drugs Have Moved J&J On To A New Phase

    October 17, 2012
    J&J is back on a growth track, but the device business needs fixing.
  23. Teleflex and Novation Team Up - Analyst Blog

    September 10, 2012
    Teleflex Incorporated (TFX), a global leader in medical devices used in critical care and surgery, was recently awarded an ...
  24. Slew of Product Recalls at Covidien - Analyst Blog

    August 24, 2012
    Recently, health care products major Covidien plc. (COV) has been hit by a number of product recalls, the most significant ...
  25. Covidien Promotes Zogenix's Product - Analyst Blog

    June 8, 2012
    The pharmaceutical unit of Covidien plc (COV) and Zogenix Inc. (ZGNX) have recently agreed to co-endorse a prescription medicine ...
  26. Covidien Reports, Ready To Spin Off Pharma

    May 4, 2012
    Covidien is looking to bridge its current valuation discount with a number of purer-play rivals.
  27. Modest But Predictable Growth At C.R. Bard

    April 26, 2012
    C.R. Bard is posting modest operational growth but there is ample downside protection.
  28. Recent IPOs Breaking Out

    March 22, 2012
    Four recent IPOs, including Silica Holdings and Cempra, are breaking out to new highs.
  29. Tyco Split Set For 2012

    January 3, 2012
    2012 will see Tyco split into another three separate companies.
  30. 2011 - Another Sick Year For Larger Med-Tech

    December 29, 2011
    Larger healthcare companies are still getting sickly returns in the market.
  31. Covidien Delivers Once Again

    November 21, 2011
    Covidien is overlooked and undervalued.
  32. Stryker Scraping By

    October 24, 2011
    Stryker's growth is modest, but the stock potential is surprising.
  33. Tyco Goes Three-For-One

    September 21, 2011
    Tyco looks to finish spinning out its last major businesses.
  34. Are Buybacks A Bad Sign?

    August 24, 2011
    Investors celebrate buybacks, but there is a cost to every decision.
  35. BD Healthy, But No Great Bargain

    August 9, 2011
    BD is not the cheapest health care name, but it comes with a lot of quality.
  36. The Perpetual Boston Scientific Turnaround Story

    August 4, 2011
    Another quarter brings another hope for better days at BSX.
  37. Covidien's Image Starting To Change

    August 3, 2011
    Find out why Covidien is much better than many investors assume.
  38. 2010: The Year In Med-Tech Deals

    December 29, 2010
    2010 was a relatively slow year for deals in the med-tech sector.
  39. Allergan Winning Wall Street's Beauty Pageant

    November 3, 2010
    Allergan's earnings aren't special, but the stock is basking in Wall Street's love. Is it simply a case of lipstick on a ...
  40. St. Jude Sews Up A Lucrative Niche

    October 19, 2010
    St. Jude pays big price tag, but gets a potential blockbuster in return.
  41. Covidien Shuffles The Deck

    June 1, 2010
    Covidien made a surprising deal to get into peripheral vascular therapies - a business with big growth potential.
  42. Intuitive Surgical - Are Robots To Be Trusted?

    June 1, 2010
    Can Intuitive Surgical produce the growth necessary to validate the stock's lofty perch?
  43. Covidien Happy With Tyco Split

    March 3, 2010
    Projections for double-digit profit increases at Covidien would easily take care of any valuation concerns at current levels. ...
  44. A Dream ADR Portfolio

    October 21, 2009
    Here are five overseas plays to help your portfolio make better use of your time.
  45. 3 Momentum Plays With Fundamental Backing

    October 27, 2008
    We examine stocks with low RSI and rising stocastic values for technical players.
Trading Center